Get the latest Science News and Discoveries

New weight loss pill beats oral Ozempic in major trial


A new once-daily weight-loss pill called orforglipron delivered better weight loss and blood sugar improvements than the leading oral semaglutide in a major clinical trial. The tablet could offer a more convenient alternative to injectable drugs like Ozempic and Wegovy because it doesn't require refrigeration or special timing with meals. It's also cheaper to manufacture, which could expand access globally.

None

Get the Android app

Or read this on ScienceDaily

Read more on:

Photo of Major trial

Major trial

Photo of oral ozempic

oral ozempic

Photo of New weight loss pill

New weight loss pill

Related news:

News photo

Vagus Nerve Stimulation Improves Severe Depression by 70%, Major US Trial Finds

News photo

Finerenone slows kidney function decline and reduces cardiovascular-kidney risk in non-diabetic chronic kidney disease, major trial shows - EurekAlert!

News photo

Major trial shows continuous glucose monitoring improves blood sugar control in people with type 2 diabetes - EurekAlert!